Triterpenoids from the flower of Campsis grandiflora K. Schum. as human Acyl-CoA: Cholesterol acyltransferase inhibitors

Archives of Pharmacal Research

Volumn 28, Issue 5, 2005, Pages 550-556

  Kim, Dong Hyun ^a   Han, Kyung Min ^a   Chung, In Sik ^a   Kim, Dae Keun ^b   Kim, Sung Hoon ^a   Kwon, Byoung Mog ^c   Jeong, Tae Sook ^c   Park, Mi Hyun ^d   Ahn, Eun Mi ^e   Baek, Nam In ^a  

^a Kyung Hee University   (South Korea)

^b Woosuk University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Erom Life Co Ltd   (South Korea)

^e Scigenic Co Led   (South Korea)

Author keywords

Bignoniaceae; Campsis grandiflora; hACAT1 inhibitory effect; Oleanolic acid; Ursolic acid

Indexed keywords

CHOLESTEROL ACYLTRANSFERASE; ENZYME INHIBITOR; TRITERPENE;

ARTICLE; BIGNONIACEAE; CHEMISTRY; DRUG ANTAGONISM; FLOWER; HUMAN; ISOLATION AND PURIFICATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION;

BIGNONIACEAE; ENZYME INHIBITORS; FLOWERS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; STEROL O-ACYLTRANSFERASE; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES;

EID: 23844501075     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977757     Document Type: Article

References (27)

1. Abdullahi, H., Nyandat, E., Galeffi, C., Messana, I., Nicoletti, M., and Bettolo, G. B., Cyclohexanols of Halleria lucida. Phytochemistry, 25, 2821-2823 (1986).
2. Accad, M., Smith, S. J., Newland, D. L., Sanan, D. A., King, L. E. Jr., Linton, M. F., Fazio, S., and Farese, R., Jr., Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA: cholesterol acyltransferase 1. J. Clin. Invest., 105, 711-719 (2000).
3. Anderson, R. A., Joyce, C., Davis, M., Reagan, J. W., Clark, M., Shelness, G. S., and Rudel L. L., Identification of a form of Acyl-CoA: Cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J. Biol. Chem., 273, 26747-26754 (1998).
4. Brecher, P. and Chan, C. T., Properties of acyl-CoA:Cholesterol O-acyltransferase in aortic microsomes from atherosclerotic rabbits. Biochem. Biophys. Acta, 617, 458-471 (1980).
5. Brown, M. S., Dana, S. E., and Goldstein, J. L., Cholsterol ester formation in cultured human fibroblasts. J. Biol. Chem., 250, 4025-4027 (1975).
6. Buhman, K. K., Accad, M., Novak, S., Choi, R. S., Wong, J. S., Hamilton, R. L., Turley, S., and Farese, R. V., Jr., Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat. Med., 6, 1341-1347 (2000).
7. Coses, S., Novak, S., Zheng, Y., Myers, H. M., Lear, S. R., Sande, E., Welch, C. B., Lusis, A. J., Spancer, T. A., Krouse, B. R., Erickson, S. K., Jr., and Farese, R. V., Jr., ACAT-2, a second mammalian acyl-CoA: Cholesterol acyltransferase. J. Biol. Chem., 273, 26755-26764 (1998).
8. Dommick, M. A., Mcguire, E. J., Reindel, J. F., Bobrowski, W. F., Bocan, T. M., and Gough, A. W., Subacute toxicity of a novel inhibitor of acyl-CoA: cholesterol acyltransferase in beagle dogs. Fundam. Appl. Toxicol., 20, 217-224 (1993).
9. Houghton, P. J. and Lian, L. M., Triterpenoids from Desfontainia spinosa. Phytochemistry, 25, 1939-1944 (1986).
10. Imakura, Y., Kobayashi, S., Kida, K., and Kido, M., Iridoid glucosides from Campsis chinensis. Phytochemistry, 23, 2263-2269 (1984).
11. Imakura, Y., Kobayashi S., and Mima, A., Bitter phenyl propanoid glycosides from Campsis chinensis. Phytochemistry, 24, 139-146 (1985).
12. Imakura, Y., Kobayashi, S., Yamahara, Y., Kihara, M., Tagawa, M., and Murai, F., Studies on constituents of Bignoniaceae plants. IV. Isolation and structure of a new iridiod glucoside, campsiside from Campsis chinensis. Chem. Pharm. Bull., 33, 2220-2227 (1985).
13. Jeong, T. S., Kim, S. U., Son, K. H., Kwon, B. M., Kim, Y. K., Choi, M. U., and Bok, S. H., GERI-BP001 compounds, new inhibitors of acyl-CoA:Cholesterol acytransferase from Aspergillus fumigatus F37. J. Antibiot., 48, 751-756 (1995).
14. Joyce, C. W., Shelness, G. S., Davis, M. A., Lee, R. G., Skinner, K., Anderson, R. A., Rudel, L. L., ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endopasmic reticulum membrane. Mol. Biol. Cell, 11, 3675-3687 (2000).
15. Kim, Y. K., Tomoda, H., and Nishida, H., Pyripyropenes, novel inhibitors of acyl-CoA:Cholesterol acyltransferase produced by Aspergillus fumigatus. J. Antibiot., 47, 154-162 (1994).
16. Kuang, H. X., Kasai, R., Ohtani, K., Liu, Z. S., Yuan, C. S., and Tanaka, O., Chemical constituents of pericarps of Rosa davurica Pall., a Traditional Chinese medicine. Chem. Pharm. Bull., 37, 2232-2233 (1989).
17. Lee, C. H., Jeong, T. S., Choi, Y. K., Hyun, B. W., Oh, G. T., Kim, E. H., Kim, J. R., Han, J. I., and Bok, S. H., Anti-atherogenic effect of citrus flanonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabits. Biochem. Biophys. Res. Commun., 284, 681-688 (2001).
18. Matsuo, M., Hashimoto, M., Suzuki, J., Iwanami, K., Tomoi, M., and Shimomura, K., Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an Acyl-CoA: Cholesterol acyltransferase inhibitor, FR145237. Toxicol. Appl. Pharmacol., 140, 387-392 (1996).
19. Roth, B. D., Blankley, J., and Hoefle, M. L., Inhibitors of acyl-CoA: Cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents. J. Med. Chem., 35, 1609-1617 (1992).
20. Rudel, L. L., Lee, R. G., and Cockman, T. L., Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr. Opin. Lipidol., 12, 121-127 (2001).
21. Shim, J. T., Park, K. M., Chung, J. Y., and Hwang, J. K., Antibacterial activity of oleanolic acid from Physalis angulata against oral pathogens. Nutraceuticals & Food, 7, 215-218 (2002).
22. Sliskovic, D. R., Picard, J. A., and Krause, B. R., 3 ACAT inhibitors: The search for a novel and effective treatment of hypercholesterolemia and atherosclerosis. Prog. Med. Chem., 39, 121-171 (2002).
23. Soka, T., Encyclopedia of Chinese Medicines, In Shanghai Science and Technology Publishing Co. (1st Ed.), Sogakukan, Tokyo, pp. 2706-2707 (1985).
24. Srivastava, S. K. and Jain, D. C., Triterpenoid saponins from plants of Araliaceae. Phytochemistry, 28, 644-647 (1989).
25. Takemoto, T., Arihara, S., Yoshikawa, K., Kusumoto, K., Yamo, I., and Hayashi, T., Studies on the constituents of Cucurbitaceae plants. VI. On the saponin constituents of Luffa cylindrica Roem. Yakugaku Zasshi, 104, 246-255 (1984).
26. Ueyama, Y., Hashimoto, S., and Furukawa K., The essential oil from the flowers of Campsis grandiflora (Thumb.) K. Schum. from China. Flavour and Fragrance J., 4, 103-107 (1989).
27. Yagyu, H., Kitamine, T., Osuga, J., Tozawa, R., Chen, Z., Kaji, Y., Oka, T., Perry, S., Tamura, Y., Ohashi, K., Okazaki, H., Yahagi, N., Shionori, F., Iizuka, Y., Harada, K., Shimano, H., Yamashita, H., Gotoda, T., Yamamda, N., and Ishibashi, S. J., Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J. Biol. Chem., 275, 21324-21330 (2000).